These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 37311719)

  • 21. Heat shock proteins expressed in the marsupial Tasmanian devil are potential antigenic candidates in a vaccine against devil facial tumour disease.
    Tovar C; Patchett AL; Kim V; Wilson R; Darby J; Lyons AB; Woods GM
    PLoS One; 2018; 13(4):e0196469. PubMed ID: 29702669
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Body temperatures and activity patterns of Tasmanian devils (Sarcophilus harrisii) and eastern quolls (Dasyurus viverrinus) through a subalpine winter.
    Jones ME; Grigg GC; Beard LA
    Physiol Zool; 1997; 70(1):53-60. PubMed ID: 9231376
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Life-history change in disease-ravaged Tasmanian devil populations.
    Jones ME; Cockburn A; Hamede R; Hawkins C; Hesterman H; Lachish S; Mann D; McCallum H; Pemberton D
    Proc Natl Acad Sci U S A; 2008 Jul; 105(29):10023-7. PubMed ID: 18626026
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fecal Viral Diversity of Captive and Wild Tasmanian Devils Characterized Using Virion-Enriched Metagenomics and Metatranscriptomics.
    Chong R; Shi M; Grueber CE; Holmes EC; Hogg CJ; Belov K; Barrs VR
    J Virol; 2019 Jun; 93(11):. PubMed ID: 30867308
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vitrification as a method for genome resource banking oocytes from the endangered Tasmanian devil (Sarcophilus harrisii).
    Czarny NA; Rodger JC
    Cryobiology; 2010 Jun; 60(3):322-5. PubMed ID: 20219455
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduced effect of Tasmanian devil facial tumor disease at the disease front.
    Hamede R; Lachish S; Belov K; Woods G; Kreiss A; Pearse AM; Lazenby B; Jones M; McCallum H
    Conserv Biol; 2012 Feb; 26(1):124-34. PubMed ID: 21978020
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Seasonality and breeding success of captive and wild Tasmanian devils (Sarcophilus harrisii).
    Keeley T; Russell T; Carmody K; Kirk G; Eastley T; Britt-Lewis A; Post M; Burridge M; Eccleston S; Faulkner T; Forge T; Leonard J; Hughes RL
    Theriogenology; 2017 Jun; 95():33-41. PubMed ID: 28460677
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HEMATOLOGICAL AND SERUM BIOCHEMICAL VALUES IN ANESTHETIZED CAPTIVE TASMANIAN DEVILS (SARCOPHILUS HARRISII).
    Hope KL; Peck S
    J Zoo Wildl Med; 2016 Jun; 47(2):564-72. PubMed ID: 27468030
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Age-related variation in the trophic characteristics of a marsupial carnivore, the Tasmanian devil
    Bell O; Jones ME; Ruiz-Aravena M; Hamede RK; Bearhop S; McDonald RA
    Ecol Evol; 2020 Jul; 10(14):7861-7871. PubMed ID: 32760570
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relict or reintroduction? Genetic population assignment of three Tasmanian devils (
    White LC; Austin JJ
    R Soc Open Sci; 2017 Apr; 4(4):170053. PubMed ID: 28484632
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hematologic and serum biochemical changes associated with Devil Facial Tumor Disease in Tasmanian Devils.
    Peck S; Corkrey R; Hamede R; Jones M; Canfield P
    Vet Clin Pathol; 2016 Sep; 45(3):417-29. PubMed ID: 27589840
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genome sequencing and analysis of the Tasmanian devil and its transmissible cancer.
    Murchison EP; Schulz-Trieglaff OB; Ning Z; Alexandrov LB; Bauer MJ; Fu B; Hims M; Ding Z; Ivakhno S; Stewart C; Ng BL; Wong W; Aken B; White S; Alsop A; Becq J; Bignell GR; Cheetham RK; Cheng W; Connor TR; Cox AJ; Feng ZP; Gu Y; Grocock RJ; Harris SR; Khrebtukova I; Kingsbury Z; Kowarsky M; Kreiss A; Luo S; Marshall J; McBride DJ; Murray L; Pearse AM; Raine K; Rasolonjatovo I; Shaw R; Tedder P; Tregidgo C; Vilella AJ; Wedge DC; Woods GM; Gormley N; Humphray S; Schroth G; Smith G; Hall K; Searle SM; Carter NP; Papenfuss AT; Futreal PA; Campbell PJ; Yang F; Bentley DR; Evers DJ; Stratton MR
    Cell; 2012 Feb; 148(4):780-91. PubMed ID: 22341448
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of antibody V segment diversity in the Tasmanian devil (Sarcophilus harrisii).
    Ujvari B; Belov K
    Vet Immunol Immunopathol; 2015 Oct; 167(3-4):156-65. PubMed ID: 26300316
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular identification of uncoupling proteins 2 and 3 in a carnivorous marsupial, the Tasmanian devil (Sarcophilus harrisii).
    Kabat AP; Rose RW; West AK
    Physiol Biochem Zool; 2004; 77(1):109-15. PubMed ID: 15057721
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence for induction of humoral and cytotoxic immune responses against devil facial tumor disease cells in Tasmanian devils (Sarcophilus harrisii) immunized with killed cell preparations.
    Kreiss A; Brown GK; Tovar C; Lyons AB; Woods GM
    Vaccine; 2015 Jun; 33(26):3016-25. PubMed ID: 25708088
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Devil declines and catastrophic cascades: is mesopredator release of feral cats inhibiting recovery of the eastern quoll?
    Fancourt BA; Hawkins CE; Cameron EZ; Jones ME; Nicol SC
    PLoS One; 2015; 10(3):e0119303. PubMed ID: 25760348
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of a SNP-based assay for measuring genetic diversity in the Tasmanian devil insurance population.
    Wright B; Morris K; Grueber CE; Willet CE; Gooley R; Hogg CJ; O'Meally D; Hamede R; Jones M; Wade C; Belov K
    BMC Genomics; 2015 Oct; 16():791. PubMed ID: 26467759
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Wearing the devil down: Rate of tooth wear varies between wild and captive Tasmanian devils.
    Pollock TI; Parrott ML; Evans AR; Hocking DP
    Zoo Biol; 2021 Sep; 40(5):444-457. PubMed ID: 34101216
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pasteurellaceae bacteria from the oral cavity of Tasmanian devils (Sarcophilus Harrisii) show high minimum inhibitory concentration values towards aminoglycosides and clindamycin.
    Gutman N; Hansen MJ; Bertelsen MF; Bojesen AM
    Lett Appl Microbiol; 2016 Mar; 62(3):237-42. PubMed ID: 26744057
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Tasmanian devil microbiome-implications for conservation and management.
    Cheng Y; Fox S; Pemberton D; Hogg C; Papenfuss AT; Belov K
    Microbiome; 2015 Dec; 3():76. PubMed ID: 26689946
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.